Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.56 -0.02 (-0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) Non Operating Investment Income (2022)

Updated

Kiora Pharmaceuticals (KPRX) reported Non Operating Investment Income of -$3,859 for FY2024, compared with -$28,379 in FY2023.

Analysis

Kiora Pharmaceuticals (KPRX) Non Operating Investment Income (2022) Analysis & Trends

Dating back to FY2020, Kiora Pharmaceuticals' Non Operating Investment Income record includes 4 years.

  • Five-year annual Non Operating Investment Income spans a low of -$28,379 in FY2023 and a high of $113,717 in FY2020.
  • According to Business Quant data, Non Operating Investment Income came in at -$28,379 in FY2023, $4,211 in FY2022 and $113,717 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kiora Pharmaceuticals 15.81 Mn 15.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 4,211.00
API Access

Kiora Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=KPRX&period=max&api_key=YOUR_API_KEY